USA stocks IPO preview
Septerna, Inc $Septerna (SEPN.US)$ Founded in 2019 and headquartered in San Francisco, California, USA, Septerna is a biotechnology company developing oral small molecule drugs targeting G protein-coupled receptors (GPCRs).
On October 21, 2024, Septerna announced plans to issue 10.9 million shares of stocks at a price range of $15 to $17, raising $0.175 billion. Based on the proposed mid-range calculation, Septerna's fully diluted market cap would reach $0.626 billion. JP Morgan Chase, TD Cowen, Cantor Fitzgerald, and Wells Fargo & Co Securities are the joint bookrunners of this trade.
Original address:https://www.mg21.com/sepn.html
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
